Renata PLC has begun shipping the anticoagulant drug Rivaroxaban to Australia, introducing the medicine in capsule form for the first time in the country. stated in a report.
The capsules, available in 15 mg and 20 mg strengths, broaden treatment options for patients requiring therapy to prevent stroke, systemic embolism, deep vein thrombosis, and pulmonary embolism.
The development marks another step in the company’s global expansion, reflecting its ability to meet strict international regulatory standards while contributing to improved access to essential medicines in overseas markets.
For more updates, be with Markedium.
Leave a comment